Alector Archives -

AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer’s disease candidate AL003, which

AbbVie cuts Alzheimer’s alliance with Alector in half

https://pharmaphorum.com/news/abbvie-cuts-alzheimers-alliance-with-alector-in-half/

Alector has launched an $208 million stock market offering as it ramps up clinical trials with AbbVie into

Alector launches $208m fundraiser for Alzheimer’s R&D with AbbVie

https://pharmaphorum.com/news/alector-launches-208m-fundraiser-as/

The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a

Alector kicks off biotech IPOs after US government shutdown

https://pharmaphorum.com/news/alector-kicks-off-biotech-ipos-after-us-government-shutdown/

Partnership will use novel approach to treating Alzheimer’s.

AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s

https://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/

Alector